Edition:
United States

People: Seattle Genetics Inc (SGEN.OQ)

SGEN.OQ on NASDAQ Stock Exchange Global Select Market

68.76USD
4:00pm EDT
Change (% chg)

$-0.42 (-0.61%)
Prev Close
$69.18
Open
$68.69
Day's High
$69.48
Day's Low
$67.98
Volume
311,441
Avg. Vol
316,443
52-wk High
$84.35
52-wk Low
$47.79

Himes, Vaughn 

Dr. Vaughn B. Himes, Ph.D. is the Chief Technical Officer of Seattle Genetics, Inc. Dr. Himes was Executive Vice President - Technical Operations and Process Sciences of Seattle Genetics, Inc. Dr. Himes joined Seattle Genetics as Executive Vice President, Technical Operations in April 2009 and has served as our Executive Vice President, Technical Operations and Process Science since July 2012. Previously, Dr. Himes was with ZymoGenetics, Inc. from November 2005 to March 2009, most recently as Senior Vice President, Technical Operations where his responsibilities included commercial and clinical manufacturing, supply chain and logistics, quality control and process development. From March 2003 to October 2005, he was Vice President, Manufacturing at Corixa, Inc. Prior to that, he held Vice President positions in manufacturing and development at Targeted Genetics and Genovo. Dr. Himes received a Bachelor of Arts in Chemistry from Pomona College in California and a Ph.D. in Chemical Engineering from the University of Minnesota.

Basic Compensation

Total Annual Compensation, USD 737,595
Restricted Stock Awards, USD 1,052,400
Long-Term Incentive Plans, USD --
All Other, USD 970,346
Fiscal Year Total, USD 2,760,340

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 40,000 1,989,100.00
Name Fiscal Year Total

Clay Siegall

8,616,340

Todd Simpson

3,061,800

Jean Liu

2,399,940

Darren Cline

--

Vaughn Himes

2,760,340

Felix Baker

575,165
As Of  30 Dec 2017